tirzepatide vs semaglutide differences efficacy side effects Frontiers Cardiovascular outcomes of semaglutide and

Head to head clinical evidence has shown greater average weight reduction with tirzepatide than semaglutide in selected adults with obesity

2 Emerging research in healthspan and longevity: In studies, Tirzepatide supported a favorable shift in body composition, more fat loss with preserved lean mass, while modulating inflammatory pathways and supporting cardiovascular health

It isn't suitable for everyone (pregnancy, certain thyroid conditions, and a history of pancreatitis are contraindications), which is exactly why the medical consultation step exists

What the inflammatory markers show A systematic review and meta-analysis confirmed that tirzepatide use is associated with significant reductions in inflammatory markers regardless of population studied or treatment regimen

This feature helps reduce the risk of low blood sugar, known as hypoglycemia

Review the complete compound tirzepatide dosing chart for extended hold protocols